ÖZKAN, M. Et Al. 2015. Is sunitinib induced hypothyrodism a predictive clinical marker for better response in metastatic renal cell carcinoma patients. american society of medical oncology .

ÖZKAN, M., KARACA, H., & BERK, V., (2015). Is sunitinib induced hypothyrodism a predictive clinical marker for better response in metastatic renal cell carcinoma patients . american society of medical oncology

ÖZKAN, METİN, Halit KARACA, And Veli BERK. "Is sunitinib induced hypothyrodism a predictive clinical marker for better response in metastatic renal cell carcinoma patients," american society of medical oncology, 2015

ÖZKAN, METİN Et Al. "Is sunitinib induced hypothyrodism a predictive clinical marker for better response in metastatic renal cell carcinoma patients." american society of medical oncology , 2015

ÖZKAN, M. KARACA, H. And BERK, V. (2015) . "Is sunitinib induced hypothyrodism a predictive clinical marker for better response in metastatic renal cell carcinoma patients." american society of medical oncology .

@conferencepaper{conferencepaper, author={METİN ÖZKAN Et Al. }, title={Is sunitinib induced hypothyrodism a predictive clinical marker for better response in metastatic renal cell carcinoma patients}, congress name={american society of medical oncology}, city={}, country={}, year={2015}}